EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trackable Tolerogenic Macrophages Integrate PD‐L1 and Rapamycin Signaling to Suppress Alloimmune Responses in Transplantation

Yihui Wang, Yuan Song, Yuji Xie, Junmin Zhang, Jing Liu, Wenyuan Wang, Ying Xu, Wenqian Wu, Wuqi Zhou, Qiaofeng Jin, Jing Wang, Yali Yang und 3 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202520420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yihui Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Macrophages, Sirolimus, B7-H1 Antigen, Transplantation Tolerance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, Hubei Provincial Young Science and Technology Talent Training Program, 77th Surface Funding Project of the China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell‐based immunotherapies represent a promising strategy for transplant tolerance, yet challenges remain in graft targeting, in vivo tracking, and comprehensive regulation of alloreactive T cells. Here, we developed trackable tolerogenic macrophages ( TTMs ), engineered to overexpress PD‐L1, incorporate azide groups for bioorthogonal labeling, and encapsulate rapamycin nanoparticles (RAPA NPs). Following intravenous administration in murine allografts, TTMs preferentially homed to inflamed grafts and were visualized in vivo. TTMs reduced graft inflammation and prolonged allograft survival up to 35 days, significantly longer than PD‐L1 or RAPA monotherapy groups. Mechanistic studies showed that PD‐L1 ligation of PD‐1 suppressed Th1 differentiation and CD8 + T‐cell activation, reducing IFN‐γ/TNF‐α and thereby attenuating complement activation and PI3K/Akt/mTOR signaling. This enhanced rapamycin‐mediated mTOR inhibition and promoted Foxp3 + Treg induction with increased IL‐10 production. The elevated IL‐10 further strengthened PD‐1/PD‐L1 signaling, forming a feedback loop that maintained a tolerogenic microenvironment. Together, these findings highlight TTMs as multifunctional therapeutic cells that integrate graft homing, real‐time tracking, and dual‐pathway immunoregulation to advance precision immunotherapy in transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesSirolimusB7-H1 AntigenTransplantation ToleranceGraft RejectionImmunosuppression TherapyNanoparticle Drug Delivery SystemMTOR InhibitorsCell TrackingAllograftsAnimalsMiceMice, Inbred BALB CMice, Inbred C57BLGraft SurvivalTh1 CellsCD4-Positive T-LymphocytesLymphocyte ActivationCell EngineeringInterferon-gammaPolylactic Acid-Polyglycolic Acid Copolymer

Stichwörter der Autor:innen

allograft rejectionalloreactive T cellmacrophageprogrammed death ligand‐1

Substanzen

SirolimusB7-H1 AntigenNanoparticle Drug Delivery SystemMTOR InhibitorsInterferon-gammaPolylactic Acid-Polyglycolic Acid Copolymer

Autor:innen und Institutionen

  • Department of Ultrasound Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Clinical Research Center for Medical Imaging in Hubei Province, Wuhan, China.
  • Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.
  • Key Laboratory of Biological Targeted Therapy, Huazhong University of Science and Technology, Ministry of Education, Wuhan, China.

ORCID-Profile: Mingxing Xie

Förderung

  • Natural Science Foundation of China
  • Hubei Provincial Young Science and Technology Talent Training Program
  • 77th Surface Funding Project of the China Postdoctoral Science Foundation
  • China Postdoctoral Science Foundation in collaboration with Hubei Province
  • Natural Science Foundation of Hubei Province
  • Postdoctoral Top Talents Introduction Project of Hubei Province
  • Natural Science Foundation of Wuhan
  • Wuhan Union Hospital

Zitieren

APA

Wang, Y., Song, Y., Xie, Y., Zhang, J., Liu, J., Wang, W., Xu, Y., Wu, W., Zhou, W., Jin, Q., Wang, J., Yang, Y., Zhang, L., Gao, T., & Xie, M. (2026). Trackable Tolerogenic Macrophages Integrate PD‐L1 and Rapamycin Signaling to Suppress Alloimmune Responses in Transplantation. Advanced Science. https://doi.org/10.1002/advs.202520420

Vancouver

Wang Y, Song Y, Xie Y, Zhang J, Liu J, Wang W, et al. Trackable Tolerogenic Macrophages Integrate PD‐L1 and Rapamycin Signaling to Suppress Alloimmune Responses in Transplantation. Advanced Science. 2026. doi:10.1002/advs.202520420

BibTeX
@article{Wang2026,
  author = {Wang, Yihui and Song, Yuan and Xie, Yuji and Zhang, Junmin and Liu, Jing and Wang, Wenyuan and Xu, Ying and Wu, Wenqian and Zhou, Wuqi and Jin, Qiaofeng and Wang, Jing and Yang, Yali and Zhang, Li and Gao, Tang and Xie, Mingxing},
  title = {Trackable Tolerogenic Macrophages Integrate PD‐L1 and Rapamycin Signaling to Suppress Alloimmune Responses in Transplantation},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202520420}
}
Kostenlos starten →